COMPARISON OF FOS-LIKE IMMUNOREACTIVITY INDUCED IN RAT-BRAIN BY CENTRAL INJECTION OF ANGIOTENSIN-II AND CARBACHOL

被引:62
|
作者
ROWLAND, NE
LI, BH
ROZELLE, AK
SMITH, GC
机构
来源
AMERICAN JOURNAL OF PHYSIOLOGY | 1994年 / 267卷 / 03期
关键词
ANGIOTENSIN TYPE I AND ANGIOTENSIN TYPE II RECEPTORS; LOSARTAN POTASSIUM; PD-123319; CGP-42112A; CIRCUMVENTRICULAR ORGANS; MEDIAN PREOPTIC NUCLEUS; SUPRAOPTIC AND PARAVENTRICULAR; HYPOTHALAMIC NUCLEI;
D O I
10.1152/ajpregu.1994.267.3.R792
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Rats were given intracerebroventricular injections of either angiotensin II (ANG II) or the cholinomimetic carbachol. Some rats received cotreatment with ANG II antagonists selective for either angiotensin receptor AT(1) (losartan) or AT(2) (PD-123319, CGP-42112A). One hour later, the rats were killed and the brains processed for immunocytochemical detection of Fos-like immunoreactivity (FLI). ANG II treatment induced strong FLI in the anterior subfornical organ (SFO), median preoptic nucleus (MnPO), organum vasculosum laminae terminalis (OVLT), and supraoptic and paraventricular hypothalamic nuclei (SON, PVH). The AT(1) antagonist abolished FLI in all regions normally stimulated by ANG II. The AT(2) antagonist PD-123319 reduced FLI in SON and PVH, but CGP-42112A was less effective. Carbachol induced strong FLI in SON, PVH, and MnPO and only moderate FLI in SFO and OVLT. The AT(1) antagonist prevented carbachol-induced FLI in the MnPO only. The distributions of FLI are compared between these central dipsogens and with that previously reported after peripheral infusion of ANG II, and their implications for mapping central thirst pathways are discussed.
引用
收藏
页码:R792 / R798
页数:7
相关论文
共 50 条
  • [1] FOS-LIKE IMMUNOREACTIVITY IN THE RAT-BRAIN IN SPONTANEOUS WAKEFULNESS AND SLEEP
    CIRELLI, C
    POMPEIANO, M
    TONONI, G
    ARCHIVES ITALIENNES DE BIOLOGIE, 1993, 131 (04): : 327 - 330
  • [2] EXPRESSION OF FOS-LIKE IMMUNOREACTIVITY BY YOHIMBINE AND CLONIDINE IN THE RAT-BRAIN
    TSUJINO, T
    SANO, H
    KUBOTA, Y
    HSIEH, ST
    MIYAJIMA, T
    SAITO, K
    NAKAJIMA, M
    SAITO, N
    YOKOYAMA, M
    EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1992, 226 (01): : 69 - 78
  • [3] EFFECTS OF SLEEP-DEPRIVATION ON FOS-LIKE IMMUNOREACTIVITY IN THE RAT-BRAIN
    POMPEIANO, M
    CIRELLI, C
    TONONI, G
    ARCHIVES ITALIENNES DE BIOLOGIE, 1992, 130 (04): : 325 - 335
  • [4] Fos-like immunoreactivity in rat brain induced by cytokine administration
    Akihiro, O
    Kokai, M
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S299 - S299
  • [5] EFFECTS OF VAGOTOMY ON CHOLECYSTOKININ-INDUCED AND DEXFENFLURAMINE-INDUCED FOS-LIKE IMMUNOREACTIVITY IN THE RAT-BRAIN
    LI, BH
    ROWLAND, NE
    BRAIN RESEARCH BULLETIN, 1995, 37 (06) : 589 - 593
  • [6] CENTRAL INJECTION OF ANGIOTENSIN-II ALTERS CATECHOLAMINE ACTIVITY IN RAT-BRAIN
    SUMNERS, C
    PHILLIPS, MI
    AMERICAN JOURNAL OF PHYSIOLOGY, 1983, 244 (02): : R257 - R263
  • [7] INDUCTION OF FOS-LIKE IMMUNOREACTIVITY IN THE RAT-BRAIN FOLLOWING PASTEURELLA-MULTOCIDA ENDOTOXIN ADMINISTRATION
    ELMQUIST, JK
    ACKERMANN, MR
    REGISTER, KB
    RIMLER, RB
    ROSS, LR
    JACOBSON, CD
    ENDOCRINOLOGY, 1993, 133 (06) : 3054 - 3057
  • [8] ANGIOTENSIN-II IMMUNOHISTOCHEMISTRY OF RAT-BRAIN
    CHANGARIS, DG
    KEIL, LC
    SEVERS, WB
    NEUROENDOCRINOLOGY, 1978, 25 (05) : 257 - 274
  • [9] ANGIOTENSIN-II RECEPTORS IN RAT-BRAIN
    SIRETT, NE
    BRAY, JJ
    HUBBARD, JI
    NEW ZEALAND MEDICAL JOURNAL, 1976, 84 (569) : 118 - 118
  • [10] Fos-like immunoreactivity in the medulla after acute and chronic angiotensin II infusion
    Li, Q
    Sullivan, MJ
    Dale, WE
    Hasser, EM
    Blaine, EH
    Cunningham, JT
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1998, 284 (03): : 1165 - 1173